loading...

EORTC Quality of Life Questionnaire - Liver Metastases Colorectal Module (EORTC QLQ-LMC21)

EORTC Quality of Life Group

ProQolid

Basic description

Developed in 2003

Authors

EORTC Quality of Life Group

Copyright
© QLQ-LMC21 Copyright 2002 EORTC Quality of life Group. All rights reserved (phase III module)
Objective
To be used in conjunction with the EORTC QLQ-C30 for assessing quality of life in patients with liver metastases from colorectal cancer
Therapeutic area
  • Digestive System Diseases
  • Neoplasms
Therapeutic indication
  • Colorectal Neoplasms
  • Liver Neoplasms
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
Translations
5 translation(s)
Bibliographic reference(s) of the original questionnaire

Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M, Buckels J; EORTC Quality of Life Group. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer. 2003 Jun;39(9):1259-63. Review (PubMed)

Blazeby JM, Fayers P, Conroy T, Sezer O, Ramage J, Rees M; European Organization for Research Treatment of Cancer (EORTC) Quality of Life Group. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg. 2009 Mar;96(3):291-8 (PubMed)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us